Noom Med review

Choose the clinical purpose before the app package

Noom Med combines access to independent clinical partners with behavioral lessons, tracking and coaching. It has a reason to make a shortlist when the reader needs prescription care and wants support putting the associated routine into practice. A broad interest in prevention or healthy aging does not itself establish a reason for medication. ^{[1] [3]}

Noom Proactive Health is separately listed with biomarker testing and its own four-week price and term schedule. Noom Weight is the non-medication behavioral programme. These offers should not be merged into one assumed purchase or used to imply that every Med subscription includes testing. ^[1]

For the distinct testing-and-treatment package, read our Noom Proactive Health review.

The branded route requires two cost decisions

Branded telehealth lists $39 to start, followed by $129 per month after month one, billed quarterly. The medication is extra. Establish the actual pharmacy price and selected product alongside the programme renewal before deciding whether the access fee is good value. ^[1]

The service can help investigate potential insurance coverage for branded medicine; the insurer decides and the Noom programme itself is not covered by insurance. Employer and private health-plan access can have different clinical charges, copayments and deductibles. A general cash-pay quote does not settle those separate arrangements. ^{[1] [3]}

Compare another clinical membership and separate medicine bill in our WeightWatchers Clinic / Med+ review.

The medication-inclusive offers have different commitments

Microdose, GLP-1Rx and GLP-1Rx Plus introductions are $79, $129 and $149. After the first four-week supply their advertised monthly rates become $179, $249 and $299, billed quarterly. Confirm the full selected charge and supply rather than treating a monthly equivalent or first shipment as the whole commitment. ^[1]

A compounded product is not an FDA-approved finished medicine or approved generic of a branded drug. FDA does not review these preparations before marketing and advises compounding for medical needs an approved product cannot meet. The actual formulation and clinician’s rationale matter; a lower-dose label does not independently establish fewer harms or a prevention benefit. ^[5]

Keep the actual selected commitment in the complete care-cost planner.

The outcome statistic needs its denominator

The current GLP-1Rx headline says up to 21 pounds in 90 days, while its self-reported footnote gives a 16.5-pound average for those following the protocol. Plus advertises up to 25 pounds with a 15.5-pound average in a much smaller 141-user dataset. Neither is an individual forecast or a controlled comparison of access services. ^[1]

The separate 37% engagement claim compares higher and lower app-use groups among 14,203 users logging weight over 40 weeks. Noom explicitly says the association is not causal. It cannot establish that purchasing the platform adds a particular benefit, preserves function or improves cardiovascular outcomes. Keep those clinical questions attached to the relevant treatment studies. ^[1]

Keep the studied product and population attached to the SELECT cardiovascular evidence.

The prescription stage can end refund eligibility

For medication-inclusive Med, the support policy stops refund eligibility once a prescription has been written. Branded telehealth may permit a refund within seven days of the first charge, but a clinical visit ends that window. A refund therefore depends on the selected programme and care stage, not simply whether the buyer has opened a shipment or used the app for a month. ^[2]

Direct subscriptions automatically renew. Cancellation must occur before 11:59 p.m. Eastern on the day before the next recurring billing date to avoid the next charge; app-store billing may differ. Renewal cancellation does not establish a credit for partially used periods. Retain the selected terms and the actual date rather than rely on a general cancel-anytime impression. ^[3]

For a different prescription-stage financial exit, read our Willow review.

The guarantee concerns access credit rather than clinical proof

The Taper Off Guarantee requires a qualifying medication plan for at least twelve months, tapering and specified engagement averaging ten NoomCoins monthly. It has a claim window and maintenance conditions. Its remedy is twelve months of the behavioral programme without clinicians or medicine, or an equivalent-value credit toward Med. It does not supply free medication or establish that stopping is appropriate. ^[3]

Noom’s clinical partners own prescribing and pharmacy decisions. Messaging, asynchronous care and video availability in some programmes are access formats, not emergency monitoring or evidence that the platform improves healthy lifespan. I would choose the package for usable clinical follow-up and behavioral support after settling the actual preparation, continuing cost and financial exit. ^{[3] [4]}

Compare the clinical purpose in our health-service comparisons.

Consider meaningful outcomes with weight loss, lean mass and function.

For a diabetes-focused medication pathway with different public care descriptions, read our T2D review.

Understanding the cost

Branded telehealth: $39 to start, then $129/month after month one, billed quarterly; medication extra. Medication-inclusive Microdose/GLP-1Rx/Plus: $79/$129/$149 introductory first four-week supplies, then $179/$249/$299 per month, billed quarterly. These are distinct prescriptions and service packages. Confirm the full selected debit, supply, renewal and any taxes; no universal all-in monthly quote. ^{[1] [3]}